assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_000756025.1_ASM75602v2	NZ_CP008731	Burkholderia mallei strain 2000031063 chromosome 2, complete sequence	1	109996-110088	1	CRISPRCasFinder	no		cas3,csa3	Orphan	TCGCCGCCGCGCGCGACGACGCGC	24	0	0	NA	NA	NA	1	1	Orphan	DinG,DEDDh,csa3,cas3,WYL	NA|86aa|up_6|NZ_CP008731.1_105766_106024_-,NA|168aa|down_3|NZ_CP008731.1_114697_115201_+,NA|170aa|down_4|NZ_CP008731.1_115258_115768_-	NA|393aa|up_9|NZ_CP008731.1_101252_102431_-	PRK07058, PRK07058, acetate/propionate family kinase	NA|468aa|up_8|NZ_CP008731.1_102427_103831_-	PRK08190, PRK08190, bifunctional enoyl-CoA hydratase/phosphate acetyltransferase; Validated	NA|598aa|up_7|NZ_CP008731.1_103841_105635_-	TIGR01838, Poly-beta-hydroxybutyrate_polymerase, poly(R)-hydroxyalkanoic acid synthase, class I	NA|86aa|up_6|NZ_CP008731.1_105766_106024_-	NA	NA|535aa|up_5|NZ_CP008731.1_105995_107600_+	PRK12597, PRK12597, F0F1 ATP synthase subunit beta; Provisional	NA|152aa|up_4|NZ_CP008731.1_107589_108045_+	PRK13447, PRK13447, F0F1 ATP synthase subunit epsilon; Provisional	NA|164aa|up_3|NZ_CP008731.1_108041_108533_+	pfam09527, ATPase_gene1, Putative F0F1-ATPase subunit Ca2+/Mg2+ transporter	NA|103aa|up_2|NZ_CP008731.1_108525_108834_+	TIGR03165, F1F0_chp_2, F1/F0 ATPase, Methanosarcina type, subunit 2	NA|234aa|up_1|NZ_CP008731.1_108830_109532_+	PRK13421, PRK13421, F0F1 ATP synthase subunit A; Provisional	NA|83aa|up_0|NZ_CP008731.1_109528_109777_+	PRK13468, PRK13468, F0F1 ATP synthase subunit C; Provisional	NA|671aa|down_0|NZ_CP008731.1_110523_112536_+	PRK13343, PRK13343, F0F1 ATP synthase subunit alpha; Provisional	NA|283aa|down_1|NZ_CP008731.1_112532_113381_+	pfam00231, ATP-synt, ATP synthase	NA|342aa|down_2|NZ_CP008731.1_113595_114621_+	cd08297, CAD3, Cinnamyl alcohol dehydrogenases (CAD)	NA|168aa|down_3|NZ_CP008731.1_114697_115201_+	NA	NA|170aa|down_4|NZ_CP008731.1_115258_115768_-	NA	NA|535aa|down_5|NZ_CP008731.1_116269_117874_+	PRK15048, PRK15048, methyl-accepting chemotaxis protein II; Provisional	NA|612aa|down_6|NZ_CP008731.1_118217_120053_-	PRK13557, PRK13557, histidine kinase; Provisional	NA|375aa|down_7|NZ_CP008731.1_120202_121327_-	COG0842, COG0842, ABC-type multidrug transport system, permease component [Defense mechanisms]	NA|1072aa|down_8|NZ_CP008731.1_121329_124545_-	COG1131, CcmA, ABC-type multidrug transport system, ATPase component [Defense mechanisms]	NA|509aa|down_9|NZ_CP008731.1_125607_127134_-	PRK09837, PRK09837, Cu(I)/Ag(I) efflux RND transporter outer membrane protein
